Literature DB >> 3524660

Evolution of the myelodysplastic syndromes.

G Tricot, C Mecucci, H Van den Berghe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3524660     DOI: 10.1111/j.1365-2141.1986.tb07544.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Acute myelogenous leukaemia in children.

Authors:  S O Lie
Journal:  Eur J Pediatr       Date:  1989-02       Impact factor: 3.183

2.  Dysmegakaryopoiesis in myelodysplastic syndromes (MDS): an immunomorphometric study of bone marrow trephine biopsy specimens.

Authors:  J Thiele; H Quitmann; S Wagner; R Fischer
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

3.  Some dynamic aspects of hematopoietic stem cells.

Authors:  David Dingli; Jorge M Pacheco
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

4.  Evolution of multiple cytogenetic clones and leukemic transformation in a case of myelodysplastic syndrome.

Authors:  E Donti; G V Donti; F Falzetti; A Rosetti; F Grignani; A Tabilio
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

Review 5.  Myelodysplastic syndromes.

Authors:  D C Doll; A F List
Journal:  West J Med       Date:  1989-08

6.  Abnormal localization of immature precursors (ALIP) detection for early prediction of acute myelocytic leukemia (AML) relapse.

Authors:  Hai-Qing Huang; Xiang-Zhong Fang; Jun Shi; Jie Hu
Journal:  Med Biol Eng Comput       Date:  2013-12-21       Impact factor: 2.602

Review 7.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12

8.  Hematologic and cytogenetic findings in myelodysplastic syndromes treated with recombinant human granulocyte colony-stimulating factor.

Authors:  K Ohyashiki; J H Ohyashiki; K Toyama; F Takaku
Journal:  Jpn J Cancer Res       Date:  1989-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.